Lumida
/HC
⌘K
HC

HC

HC
$25.39USD+3.13%+0.77 today

MARKET CAP

0

P/E (TTM)

FWD P/E

DAY RANGE

$24 – $26

52W RANGE

$17
$27

The case for & against

Bull & Bear analysis

Bullish

HCA Healthcare Inc. (HCA) is a leading healthcare provider in the U.S., specializing in the management of acute care hospitals and outpatient facilities. HCA operates over 180 hospitals and has a significant presence in multiple market segments, catering to varied patient needs. As a robust player in the healthcare services sector, the company remains positioned to capitalize on the ongoing trends in healthcare spending, demand for outpatient services, and shifts towards value-based care.

Bull says

  • EPS $7.59 and 15% YoY revenue growth to $20.23B beat estimates.
  • Quarterly dividend $0.78 and FCF/EV ~1.77 indicate strong cash returns.
  • Analysts rate Moderate Buy with $462.64 target; stock surged 5.3%.
  • Management cites operational strength easing inflation impacts; high profitability metrics.
  • Undervalued ~8% vs GF Value™ $460.05; strong momentum factors support upside.
  • Positive earnings revision and profitability factors bolster growth outlook.

Bear says

  • Inflation pressures and payer-mix shifts may erode operational efficiency.
  • Negative sales-growth factor signals weakening future revenue expansion.
  • Balance sheet leverage risk suggests liquidity vulnerabilities amid policy changes.
  • High market volatility factor may drive share price swings.
  • Analysts cutting EPS forecasts indicate potential future earnings pressure.
  • Increased competition and tightening margins could hamper profit growth.